Hennion & Walsh Asset Management, Inc. Immunocore Holdings PLC Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.35 Billion
- Q2 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 66,780 shares of IMCR stock, worth $2.14 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
66,780
Previous 62,555
6.75%
Holding current value
$2.14 Million
Previous $1.85 Million
13.24%
% of portfolio
0.09%
Previous 0.09%
Shares
7 transactions
Others Institutions Holding IMCR
# of Institutions
133Shares Held
44.6MCall Options Held
219KPut Options Held
125K-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.05MShares$226 Million0.14% of portfolio
-
Wellington Management Group LLP Boston, MA6.13MShares$197 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$156 Million2.37% of portfolio
-
Primecap Management CO Pasadena, CA2.68MShares$86 Million0.07% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$74.6 Million0.82% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.41B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...